Valens SVP sells 3,600 shares after option exercise

Valens Semiconductor Ltd.’s SVP, R&D Chairman David reported an exercise-and-sell transaction in Ordinary Shares.

Rhea-AI Filing Summary

Valens Semiconductor Ltd.’s SVP, R&D Chairman David reported an exercise-and-sell transaction in Ordinary Shares. On April 23, 2026, he exercised stock options for 3,600 shares at $0.86 per share and sold the same 3,600 shares at a weighted average price of $1.6654 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he holds 403,968 Ordinary Shares directly and retains 87,695 stock options, making this a relatively small, routine disposition compared with his remaining position.

Insider Trade Summary 10b5-1

Exercise and Sale: 3,600 shares ($3K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Chairman David

Role SVP, R&D

Sold 3,600 shs ($6K)

Approx. gross sale proceeds $6K

Approx. exercise cost $3K

Approx. pre-tax spread $3K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	3,600	$0.00	$0.00
Exercise	Ordinary Shares	3,600	$0.86	$3K
Sale	Ordinary Shares	3,600	$1.6654	$6K

Holdings After Transaction: Stock Option (Right to Buy) — 87,695 contracts (Direct); Ordinary Shares — 403,968 shares (Direct)

Footnotes (5)

1. F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
2. F2. The shares were acquired upon the exercise of stock options
3. F3. The shares sold were acquired upon the exercise of stock options on the same date
4. F4. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
5. F5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

Key Figures

Shares sold: 3,600 shares Sale price: $1.6654 per share Option exercise price: $0.86 per share +4 more

7 metrics

Shares sold 3,600 shares Ordinary Shares sold in open market on April 23, 2026

Sale price $1.6654 per share Weighted average sale price for 3,600 Ordinary Shares

Option exercise price $0.86 per share Exercise price for 3,600 stock options

Shares held after 403,968 shares Direct Ordinary Share ownership following transactions

Options remaining 87,695 options Stock options remaining after exercising 3,600 options

Transaction date April 23, 2026 Date of option exercise and share sale

10b5-1 plan adoption August 16, 2024 Date Rule 10b5-1 trading plan was adopted

Key Terms

Rule 10b5-1 trading plan, stock options, weighted average price, derivative security, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

stock options financial

"The shares were acquired upon the exercise of stock options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

weighted average price financial

"The price reported is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Valens Semiconductor (VLN) report on this Form 4?

Valens Semiconductor reported that SVP, R&D Chairman David exercised stock options for 3,600 Ordinary Shares and sold the same 3,600 shares in an open-market transaction, combining an option exercise with a same-day sale of the acquired shares.

How many Valens Semiconductor (VLN) shares did the insider sell and at what price?

The insider sold 3,600 Valens Semiconductor Ordinary Shares at a weighted average price of $1.6654 per share. These shares were first acquired by exercising stock options and then disposed of in an open-market sale on the same date.

What stock options did the Valens Semiconductor (VLN) executive exercise?

The executive exercised stock options covering 3,600 Ordinary Shares at an exercise price of $0.86 per share. These options had an original exercise date of June 1, 2022 and an expiration date of June 9, 2031, according to the reported derivative security information.

How many Valens Semiconductor (VLN) shares does the insider own after the transaction?

After the reported transactions, the insider directly owns 403,968 Valens Semiconductor Ordinary Shares. This post-transaction balance indicates that the 3,600 shares sold represent a small portion of the insider’s overall direct equity position in the company.

Were the Valens Semiconductor (VLN) insider sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were effectuated under a Rule 10b5-1 trading plan adopted on August 16, 2024. Such plans pre-schedule trades, making the timing more routine and reducing the significance of short-term market conditions.

Does the Valens Semiconductor (VLN) insider still hold stock options after this Form 4?

Yes. After exercising 3,600 stock options, the insider still holds 87,695 stock options. These options are linked to Valens Semiconductor Ordinary Shares and retain their original expiration date of June 9, 2031, as reflected in the derivative holdings table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 06:40 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chairman David

(Last) (First) (Middle)

42 HOLOT GEULIM

(Street)

ZORAN

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/23/2026		M(1)		3,600(2)	A	$0.86	407,568	D
Ordinary Shares	04/23/2026		S(1)		3,600(3)	D	$1.6654(4)	403,968	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.86	04/23/2026		M(5)			3,600	06/01/2022	06/09/2031	Ordinary Shares	3,600	$0	87,695	D

Explanation of Responses:

1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024

2. The shares were acquired upon the exercise of stock options

3. The shares sold were acquired upon the exercise of stock options on the same date

4. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.

5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

	David Chairman by: Oppenheimer Israel, as Attorney-in-fact	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)